Vision

Discovering the unique characteristics of cellular prion-like molecules, opening up a new research field on prion-like protein function, establishing novel therapeutic theory, screening potential candidate drugs and entering clinic trials--GBS has done it all by itself in Taiwan. Its current mission is to collaborate with renowned pharmaceutical companies on accelerating their drug development projects. GBS expects to develop the first novel drug based on prion-like mechanism research.

Milestones